Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies, has raised $134 million in financing. The investors include the SBI Group, Japan and Rakuten Inc.
Source: Press Release
Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies, has raised $134 million in financing. The investors include the SBI Group, Japan and Rakuten Inc.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.